BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 4756401)

  • 1. [Therapeutic effect of d-penicillamine in scleroderma].
    Bogdanikowa B; Rudy J; Bernacka K; Palka Z
    Pol Tyg Lek; 1973 Aug; 28(34):1317-20. PubMed ID: 4756401
    [No Abstract]   [Full Text] [Related]  

  • 2. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
    Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [D-penicillamine therapy of chronic polyarthritis].
    Günther R; Gabl F; Knapp E
    Z Rheumaforsch; 1973; 32(7):313-25. PubMed ID: 4741805
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term use of D-penicillamine in systemic scleroderma and rheumatoid arthritis].
    Guseva NG; Trofimova TM; Oskilko TG; Panasiuk AF; Tarasenkova TA
    Klin Med (Mosk); 1986 Jun; 64(6):44-50. PubMed ID: 3747436
    [No Abstract]   [Full Text] [Related]  

  • 5. D-penicillamine-induced pemphigus vulgaris in a patient with scleroderma-rheumatoid arthritis overlap syndrome.
    Szegedi A; Surányi P; Szücs G; Kiss M; Hunyadi J; Gaál J
    Acta Derm Venereol; 2004; 84(4):318-9. PubMed ID: 15339083
    [No Abstract]   [Full Text] [Related]  

  • 6. [D-penicillamine in the treatment of progressive systemic sclerosis].
    Marques Neto JF; Manzato LC; Samara AM
    AMB Rev Assoc Med Bras; 1980 Jun; 26(6):191-3. PubMed ID: 6970374
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)].
    Bröll H; Tausch G; Eberl R
    Wien Klin Wochenschr; 1976 Apr; 88(9):292-5. PubMed ID: 973388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic use of d-penicillamine].
    Bogdanikowa B
    Pol Tyg Lek; 1972 Oct; 27(41):1612-3. PubMed ID: 4581541
    [No Abstract]   [Full Text] [Related]  

  • 9. [Penicillamine in the treatment of scleroderma].
    Kobíková M; Stáva Z
    Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of progressive scleroderma with D-penicillamine (Metalcaptase)].
    Böni A; Pavelka K; Kludas M
    Munch Med Wochenschr; 1969 Aug; 111(31):1580-4. PubMed ID: 5394493
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)].
    Helmke K; Velcovsky HG; Federlin K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2198-203. PubMed ID: 1080704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience using d-penicillamine in systemic scleroderma].
    Nemchinov EN; Krel' AA; Shekhter AB; Rashchupkina ZP
    Klin Med (Mosk); 1982 Jan; 60(1):77-82. PubMed ID: 7078046
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of Cuprenil (D-penicillamine) treatment in patients with rheumatoid arthritis].
    Maldykowa H; Chwalińska-Sadowska H; Luft S; Glińska-Urban D; Mikolajew M; Odrzywolska A; Jaworska H
    Reumatologia; 1972; 10(1):9-21. PubMed ID: 5019762
    [No Abstract]   [Full Text] [Related]  

  • 14. Nephrotic syndrome induced by penicillamine.
    Stein J; Smythe HA
    Can Med Assoc J; 1968 Mar; 98(10):505-7. PubMed ID: 5645186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma].
    Alekperov RT; Avdeev SN; Kotovskaia MA
    Ter Arkh; 2004; 76(3):74-6. PubMed ID: 15108466
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of penicillamine in the treatment of rheumatoid arthritis and scleroderma.
    Baum J
    Scand J Rheumatol Suppl; 1979; (28):65-70. PubMed ID: 377472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case of the development of the nephrotic syndrome in a female patient with systemic scleroderma against a D-penicillamine treatment background].
    Grebeneva LS
    Vopr Revm; 1979; (1):51-3. PubMed ID: 425416
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis.
    Nishikai M; Funatsu Y; Homma M
    Arch Dermatol; 1974 Aug; 110(2):253-5. PubMed ID: 4853253
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proteinuria in immunopathological diseases during long-term penicillamine therapy (author's transl)].
    Hrncír Z; Tichý M
    Cas Lek Cesk; 1976 May; 115(18):549-51. PubMed ID: 1277236
    [No Abstract]   [Full Text] [Related]  

  • 20. Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis.
    Kahl LE; Medsger TA; Klein I
    J Rheumatol; 1985 Oct; 12(5):990-1. PubMed ID: 4087275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.